Aquestive Therapeutics, Inc. (AQST)

USD 2.52

(2.02%)

Revenue Summary of Aquestive Therapeutics, Inc.

  • Aquestive Therapeutics, Inc.'s latest annual revenue in 2023 was 50.58 Million USD , up 6.09% from previous year.
  • Aquestive Therapeutics, Inc.'s latest quarterly revenue in 2024 Q2 was 20.09 Million USD , up 66.76% from previous quarter.
  • Aquestive Therapeutics, Inc. reported a annual revenue of 47.68 Million USD in annual revenue 2022, down -6.2% from previous year.
  • Aquestive Therapeutics, Inc. reported a annual revenue of 50.83 Million USD in annual revenue 2021, up 10.87% from previous year.
  • Aquestive Therapeutics, Inc. reported a quarterly revenue of 12.05 Million USD for 2024 Q1, down -8.73% from previous quarter.
  • Aquestive Therapeutics, Inc. reported a quarterly revenue of 13.54 Million USD for 2024 Q3, down -32.62% from previous quarter.

Annual Revenue Chart of Aquestive Therapeutics, Inc. (2023 - 2016)

Historical Annual Revenue of Aquestive Therapeutics, Inc. (2023 - 2016)

Year Revenue Revenue Growth
2023 50.58 Million USD 6.09%
2022 47.68 Million USD -6.2%
2021 50.83 Million USD 10.87%
2020 45.84 Million USD -12.85%
2019 52.6 Million USD -21.98%
2018 67.43 Million USD 0.77%
2017 66.91 Million USD 29.22%
2016 51.78 Million USD 0.0%

Peer Revenue Comparison of Aquestive Therapeutics, Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 91.075%
Embecta Corp. 1.12 Billion USD 95.487%
ANI Pharmaceuticals, Inc. 486.81 Million USD 89.609%
Dynavax Technologies Corporation 232.28 Million USD 78.224%
Esperion Therapeutics, Inc. 116.33 Million USD 56.519%
Pacira BioSciences, Inc. 674.97 Million USD 92.506%
PainReform Ltd. - USD -Infinity%
Sunshine Biopharma, Inc. 24.09 Million USD -109.951%
SCYNEXIS, Inc. 140.14 Million USD 63.906%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -2522.923%
Cosmos Health Inc. 53.37 Million USD 5.234%
Journey Medical Corporation 79.18 Million USD 36.117%
Sunshine Biopharma, Inc. 24.09 Million USD -109.951%
Safety Shot Inc 202.67 Thousand USD -24858.307%
Alpha Teknova, Inc. 36.68 Million USD -37.888%
Intra-Cellular Therapies, Inc. 464.37 Million USD 89.107%
Bright Green Corporation 401.49 Thousand USD -12498.788%
Procaps Group, S.A. 409.92 Million USD 87.66%
Theratechnologies Inc. 81.76 Million USD 38.135%
Harrow Health, Inc. 130.19 Million USD 61.148%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -297.197%
Biofrontera Inc. 34.07 Million USD -48.464%
DURECT Corporation 8.54 Million USD -491.752%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 91.674%
Cronos Group Inc. 88.84 Million USD 43.063%
OptiNose, Inc. 70.98 Million USD 28.743%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 88.575%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -676.626%
Organogenesis Holdings Inc. 433.14 Million USD 88.322%
Guardion Health Sciences, Inc. 12.24 Million USD -312.971%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -27.888%
Radius Health, Inc. 2.88 Billion USD 98.245%
Universe Pharmaceuticals INC 32.3 Million USD -56.561%
ProPhase Labs, Inc. 44.38 Million USD -13.967%
Phibro Animal Health Corporation 1.01 Billion USD 95.03%
Procaps Group S.A. 409.92 Million USD 87.66%
Alvotech 91.43 Million USD 44.678%
TherapeuticsMD, Inc. 1.3 Million USD -3785.023%
Viatris Inc. 15.42 Billion USD 99.672%
Rockwell Medical, Inc. 83.61 Million USD 39.503%
Aytu BioPharma, Inc. 81 Million USD 37.553%
SIGA Technologies, Inc. 139.91 Million USD 63.848%
Tilray Brands, Inc. 788.94 Million USD 93.589%
Lifecore Biomedical, Inc. 128.26 Million USD 60.562%
Shineco, Inc. 9.8 Million USD -416.055%
PetIQ, Inc. 1.1 Billion USD 95.41%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -421425.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 97.32%
Alimera Sciences, Inc. 80.75 Million USD 37.362%
Silver Spike Investment Corp. 11.72 Million USD -331.517%
Assertio Holdings, Inc. 152.06 Million USD 66.737%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -768.767%
Clever Leaves Holdings Inc. 17.41 Million USD -190.423%
Cyclo Therapeutics, Inc. 1.07 Million USD -4599.254%
Avadel Pharmaceuticals plc 27.96 Million USD -80.893%
Hempacco Co., Inc. 4.04 Million USD -1150.31%
Talphera, Inc. 651 Thousand USD -7670.046%
Alvotech 91.43 Million USD 44.678%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 84.024%
Lantheus Holdings, Inc. 1.29 Billion USD 96.098%
Currenc Group, Inc. 53.25 Million USD 5.018%
Kamada Ltd. 144.75 Million USD 65.057%
Indivior PLC 1.09 Billion USD 95.372%
Evoke Pharma, Inc. 5.18 Million USD -876.387%
Flora Growth Corp. 76.07 Million USD 33.506%
Cyclo Therapeutics, Inc. 1.07 Million USD -4599.254%
Evolus, Inc. 202.08 Million USD 74.969%
HUTCHMED (China) Limited 837.99 Million USD 93.964%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 92.15%
Akanda Corp. 2.16 Million USD -2241.749%